Oh no, Ozempic! Eli Lilly’s New Weight-Loss Drug KOs Rival Treatments

Oh no, Ozempic! Eli Lilly’s New Weight-Loss Drug KOs Rival Treatments

How do you swear in Danish? Our AI chatbots are much too polite to help us out here, but we suspect you would have heard them all echoing outside the offices of Novo Nordisk yesterday.  Eli Lilly, its leading rival in the burgeoning weight-loss drug market, announced trial results for an experimental obesity drug that helped patients lose more weight than with any other treatment on the market. Feeling Dizzy Indianapolis-headquartered Lilly is n…